Adolfo González Serrano

Adolfo González Serrano is a researcher at the University of Paris-Est Créteil (UPEC), affiliated with the Mondor Biomedical Research Institute (IMRB) and Inserm Unit U955. His work focuses on optimizing cancer treatment strategies for elderly patients through rigorous epidemiological and clinical research.

He completed a thesis in public health specializing in epidemiology, investigating the clinical and economic consequences of prostate cancer treatment based on vulnerability profiles in the elderly.

His core research interests include:

• Epidemiology and cohort study design
• Oncology (prostate cancer, solid tumors)
• Geriatric assessment and frailty metrics
• Health economics and treatment cost analysis
• Clinical decision-making frameworks
• Public health policy for aging populations

Recent publications (2021-2023) demonstrate a consistent focus on improving outcomes for elderly cancer patients. Key trends include developing validated frailty assessment tools, analyzing adherence to treatment guidelines, and applying decision curve analysis to optimize therapeutic strategies. These studies predominantly utilize prospective multicenter cohort methodologies to evaluate survival outcomes and economic impacts.

Dr. González Serrano actively contributes to the IMRB research ecosystem at UPEC, collaborating with clinical and epidemiological teams to advance biomedical understanding of aging-related cancer vulnerabilities.